Nuvalent Inc. (NUVL)
NASDAQ: NUVL
· Real-Time Price · USD
74.92
-0.61 (-0.81%)
At close: Jun 20, 2025, 3:59 PM
75.00
0.11%
After-hours: Jun 20, 2025, 04:20 PM EDT
-0.81% (1D)
| Bid | 70.86 |
| Market Cap | 5.38B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -300.86M |
| EPS (ttm) | -4.31 |
| PE Ratio (ttm) | -17.38 |
| Forward PE | -15.29 |
| Analyst | Buy |
| Ask | 84.4 |
| Volume | 313,413 |
| Avg. Volume (20D) | 570,441 |
| Open | 75.57 |
| Previous Close | 75.53 |
| Day's Range | 73.75 - 76.24 |
| 52-Week Range | 55.53 - 113.51 |
| Beta | 1.34 |
About NUVL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NUVL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NUVL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts9 months ago
-6.61%
Nuvalent shares are trading lower after the compan...
Unlock content with
Pro Subscription
9 months ago
+28.27%
Nuvalent shares are trading higher after the company highlighted results for its ROS1 and ALK-Positive NSCLC programs and accelerated its development timeline. Also, the company announced a $350 million public offering and multiple firms raised their respective price targets on the stock.
